Immediate Impact
63 standout
Citing Papers
Systemic Lupus Erythematosus
2024 Standout
Neutrophils in Cancer immunotherapy: friends or foes?
2024 Standout
Works of Sofia de Achaval being referenced
Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.
2023
Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Sofia de Achaval | 10 | 22 | 70 | 170 | 85 | 13 | 383 | |
| Amber Servi | 20 | 14 | 31 | 149 | 156 | 8 | 444 | |
| Herman L. M. Brus | 3 | 10 | 73 | 307 | 64 | 12 | 442 | |
| Antonio Aviña-Zubieta | 13 | 23 | 26 | 158 | 29 | 16 | 365 | |
| Hanneke Zwikker | 15 | 2 | 73 | 205 | 198 | 11 | 423 | |
| Anthony Louder | 32 | 56 | 22 | 68 | 42 | 17 | 345 | |
| J Barr | 91 | 6 | 45 | 64 | 20 | 15 | 418 | |
| Diane McNally | 40 | 53 | 52 | 76 | 19 | 23 | 370 | |
| S. N. | 54 | 7 | 94 | 76 | 28 | 20 | 458 | |
| Laura Horne | 60 | 57 | 17 | 77 | 24 | 22 | 401 | |
| Steven K. Magid | 25 | 12 | 16 | 75 | 21 | 26 | 353 |
All Works
Loading papers...